Sticky Post
On Tuesday, March 19, the FDA announced approval of (brand name) Zulresso, a first of it’s kind medication for Postpartum Depression. Zulresso (generic name is brexanolone) was developed through clinical trials by pharmaceutical company, Sage Therapeutics. You can find more about the development and history of Zulresso HERE. The medication is potentially a game-changer for...
Read More